Journal article
Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study
Abstract
Rationale: Early relapse (ER) within 12 months of Autologous Hematopoietic Stem Cell Transplantation (AHCT) is currently accepted as functional high risk among patients diagnosed with Multiple Myeloma (MM). Efforts to predict ER has led to different risk scores developed by CIBMTR, GIMEMA and EBMT. CIBMTR and GIMEMA score integrates parameters not always available (bone marrow plasma cell percentage prior to AHCT, lambda light chain, FISH and …
Authors
Beksac M; Iacobelli S; Gras L; Koster L; Baaij L; Hamad N; D'Souza A; Estrada-Merly N; Hari PN; Cowan AJ
Journal
Blood, Vol. 144, No. Supplement 1, pp. 4733–4733
Publisher
American Society of Hematology
Publication Date
November 5, 2024
DOI
10.1182/blood-2024-200071
ISSN
0006-4971